Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Conmed price target lowered to $110 from $160 at Stifel » 06:47
06/23/22
06/23
06:47
06/23/22
06:47
CNMD

Conmed

$89.59 /

+0.16 (+0.18%)

Stifel analyst Rick Wise…

Stifel analyst Rick Wise lowered the firm's price target on Conmed to $110 from $160 and keeps a Buy rating on the shares. Recent conversations with foot-and-ankle orthopedic surgeons/podiatrists to better understand Conmed's just-closed In2Bones acquisition left Wise encouraged that In2Bones does represent a meaningful addition to Conmed's Orthopedic Surgery division, opening up the faster-growing extremities market, the analyst tells investors in a research note. The analyst believes the In2Bones transaction will prove to be a compelling, highly-complementary addition to Conmed's portfolio for years to come.

ShowHide Related Items >><<
CNMD Conmed
$89.59 /

+0.16 (+0.18%)

CNMD Conmed
$89.59 /

+0.16 (+0.18%)

04/19/22 Piper Sandler
Piper Sandler continues to recommend exposure to medtech space after J&J results
03/02/22 BofA
Conmed reinstated with a Neutral at BofA
10/27/21 Piper Sandler
Conmed should be bought on any weakness, says Piper Sandler
10/06/21
Fly Intel: Top five analyst upgrades
CNMD Conmed
$89.59 /

+0.16 (+0.18%)

CNMD Conmed
$89.59 /

+0.16 (+0.18%)

Over a week ago
Hot Stocks
Conmed completes acquisition of In2Bones Global » 16:08
06/13/22
06/13
16:08
06/13/22
16:08
CNMD

Conmed

$96.02 /

-6.94 (-6.74%)

CONMED "announced…

CONMED "announced that it has completed its previously announced acquisition of privately-held In2Bones Global Inc. The transaction is being financed through a combination of the net proceeds of the Company's 2.25% convertible notes, which were issued on June 6, 2022, borrowings under the Company's amended and restated credit facility, and cash on hand. The Company will provide additional guidance regarding the impact of the transaction on 2022 financial results when it reports second quarter financial results in late July."

ShowHide Related Items >><<
CNMD Conmed
$96.02 /

-6.94 (-6.74%)

CNMD Conmed
$96.02 /

-6.94 (-6.74%)

04/19/22 Piper Sandler
Piper Sandler continues to recommend exposure to medtech space after J&J results
03/02/22 BofA
Conmed reinstated with a Neutral at BofA
10/27/21 Piper Sandler
Conmed should be bought on any weakness, says Piper Sandler
10/06/21
Fly Intel: Top five analyst upgrades
CNMD Conmed
$96.02 /

-6.94 (-6.74%)

CNMD Conmed
$96.02 /

-6.94 (-6.74%)

On The Fly
Fly Intel: After-Hours Movers » 17:40
05/31/22
05/31
17:40
05/31/22
17:40
CRM

Salesforce

$160.60 /

-4.5 (-2.73%)

, VSCO

Victoria's Secret

$41.27 /

-1.37 (-3.21%)

, VTOL

Bristow Group

$31.73 /

+0.04 (+0.13%)

, SIX

Six Flags

$29.36 /

-0.64 (-2.13%)

, HPQ

HP Inc.

$38.79 /

+0.06 (+0.15%)

, LPI

Laredo Petroleum

$84.19 /

-0.75 (-0.88%)

, OSTK

Overstock.com

$31.02 /

-1.295 (-4.01%)

, AMBA

Ambarella

$85.23 /

-2.895 (-3.29%)

, SPWH

Sportsman's Warehouse

$9.45 /

-0.11 (-1.15%)

, APPS

Digital Turbine

$25.45 /

-1.16 (-4.36%)

, CHPT

ChargePoint

$12.75 /

-0.71 (-5.27%)

, CNCE

Concert Pharmaceuticals

$6.36 /

+0.5 (+8.53%)

, CNMD

Conmed

$116.37 /

+0.315 (+0.27%)

Check out this evening's…

ShowHide Related Items >><<
VTOL Bristow Group
$31.73 /

+0.04 (+0.13%)

VSCO Victoria's Secret
$41.27 /

-1.37 (-3.21%)

SPWH Sportsman's Warehouse
$9.45 /

-0.11 (-1.15%)

SIX Six Flags
$29.36 /

-0.64 (-2.13%)

OSTK Overstock.com
$31.02 /

-1.295 (-4.01%)

LPI Laredo Petroleum
$84.19 /

-0.75 (-0.88%)

HPQ HP Inc.
$38.79 /

+0.06 (+0.15%)

CRM Salesforce
$160.60 /

-4.5 (-2.73%)

CNMD Conmed
$116.37 /

+0.315 (+0.27%)

CNCE Concert Pharmaceuticals
$6.36 /

+0.5 (+8.53%)

CHPT ChargePoint
$12.75 /

-0.71 (-5.27%)

APPS Digital Turbine
$25.45 /

-1.16 (-4.36%)

AMBA Ambarella
$85.23 /

-2.895 (-3.29%)

CRM Salesforce
$160.60 /

-4.5 (-2.73%)

05/24/22 BofA
Salesforce, CNH removed from US 1 list at at BofA
05/24/22 Oppenheimer
Salesforce price target lowered to $205 from $310 at Oppenheimer
05/23/22 Jefferies
Salesforce price target lowered to $260 from $330 at Jefferies
05/23/22 Cowen
Salesforce price target lowered to $225 from $285 at Cowen
VSCO Victoria's Secret
$41.27 /

-1.37 (-3.21%)

05/16/22 JPMorgan
Victoria's Secret price target lowered to $71 from $86 at JPMorgan
04/05/22 Wells Fargo
Victoria's Secret price target lowered to $70 from $75 at Wells Fargo
04/01/22 Barclays
Victoria's Secret price target lowered to $61 from $76 at Barclays
03/03/22 BMO Capital
Victoria's Secret price target lowered to $72 from $80 at BMO Capital
VTOL Bristow Group
$31.73 /

+0.04 (+0.13%)

SIX Six Flags
$29.36 /

-0.64 (-2.13%)

05/13/22 Truist
Six Flags price target lowered to $32 from $46 at Truist
05/13/22 Jefferies
Six Flags remains a 'top pick' after Q1 results, says Jefferies
05/13/22 Stifel
Six Flags' post-earnings reaction 'perplexing,' says Stifel
05/13/22 Deutsche Bank
Six Flags price target lowered to $56 from $57 at Deutsche Bank
HPQ HP Inc.
$38.79 /

+0.06 (+0.15%)

05/25/22 JPMorgan
HP Inc. price target lowered to $39 from $41 at JPMorgan
05/23/22 Citi
HP Inc. downgraded to Neutral from Buy at Citi
05/18/22 Jefferies
Information Technology sector upgraded to Bullish at Jefferies
05/16/22 Evercore ISI
HP Inc. added to 'Tactical Outperform' list at Evercore ISI
LPI Laredo Petroleum
$84.19 /

-0.75 (-0.88%)

05/24/22 Raymond James
Laredo Petroleum price target lowered to $85 from $120 at Raymond James
04/07/22 Piper Sandler
Laredo Petroleum upgraded to Overweight from Neutral at Piper Sandler
03/23/22 Raymond James
Laredo Petroleum price target raised to $100 from $85 at Raymond James
03/10/22 Piper Sandler
Laredo Petroleum price target raised to $93 from $79 at Piper Sandler
OSTK Overstock.com
$31.02 /

-1.295 (-4.01%)

05/17/22 Wedbush
Overstock.com removed from Best Ideas List at Wedbush
04/28/22 Wedbush
Overstock.com price target lowered to $66 from $95 at Wedbush
04/25/22 BofA
BofA cuts Overstock.com to Neutral, sees revenue down 9%
04/25/22 BofA
Overstock.com downgraded to Neutral from Buy at BofA
AMBA Ambarella
$85.23 /

-2.895 (-3.29%)

05/27/22 Jefferies
Ambarella price target lowered to $136 from $160 at Jefferies
05/26/22 Wells Fargo
Ambarella price target lowered to $125 from $175 at Wells Fargo
04/20/22 Deutsche Bank
Ambarella price target lowered to $115 from $140 at Deutsche Bank
03/18/22 Jefferies
2022 could be inflection year for Ambarella advanced ADAS wins, says Jefferies
SPWH Sportsman's Warehouse
$9.45 /

-0.11 (-1.15%)

05/17/22 B. Riley
Sportsman's Warehouse initiated with a Buy at B. Riley
03/30/22 Piper Sandler
Sportsman's Warehouse price target raised to $12 from $11 at Piper Sandler
12/28/21 Lake Street
Lake Street names 18 small cap best ideas for 2022
12/06/21 Lake Street
Sportsman's Warehouse upgraded to Buy from Hold at Lake Street
APPS Digital Turbine
$25.45 /

-1.16 (-4.36%)

02/16/22 Roth Capital
Roth says Google news creates more unwarranted noise around Digital Turbine
02/16/22 Oppenheimer
Google changes to make Digital Turbine access 'more valuable,' says Oppenheimer
02/09/22 Maxim
Digital Turbine price target lowered to $108 from $132 at Maxim
02/09/22 Macquarie
Digital Turbine price target lowered to $70 from $80 at Macquarie
CHPT ChargePoint
$12.75 /

-0.71 (-5.27%)

05/26/22 JPMorgan
ChargePoint price target lowered to $18 from $22 at JPMorgan
04/21/22 Tudor Pickering
ChargePoint initiated with a Buy at Tudor Pickering
03/29/22 Stifel
Partnership with GS Renewable Power positive for ChargePoint, says Stifel
03/15/22 BofA
ChargePoint topline growth 'set to soar' as cash burn accelerates, says BofA
CNCE Concert Pharmaceuticals
$6.36 /

+0.5 (+8.53%)

05/23/22 H.C. Wainwright
Concert has potential best-in-class alopecia areata drug, says H.C. Wainwright
05/23/22 Mizuho
Concert Phase 3 data in alopecia areata 'impressive,' says Mizuho
11/12/21 JMP Securities
Concert Pharmaceuticals price target lowered to $10 from $17 at JMP Securities
10/05/21 Mizuho
Concert Pharmaceuticals price target lowered to $9 from $13 at Mizuho
CNMD Conmed
$116.37 /

+0.315 (+0.27%)

04/19/22 Piper Sandler
Piper Sandler continues to recommend exposure to medtech space after J&J results
03/02/22 BofA
Conmed reinstated with a Neutral at BofA
10/27/21 Piper Sandler
Conmed should be bought on any weakness, says Piper Sandler
10/06/21
Fly Intel: Top five analyst upgrades
VTOL Bristow Group
$31.73 /

+0.04 (+0.13%)

VSCO Victoria's Secret
$41.27 /

-1.37 (-3.21%)

SPWH Sportsman's Warehouse
$9.45 /

-0.11 (-1.15%)

SIX Six Flags
$29.36 /

-0.64 (-2.13%)

OSTK Overstock.com
$31.02 /

-1.295 (-4.01%)

LPI Laredo Petroleum
$84.19 /

-0.75 (-0.88%)

HPQ HP Inc.
$38.79 /

+0.06 (+0.15%)

CRM Salesforce
$160.60 /

-4.5 (-2.73%)

CNMD Conmed
$116.37 /

+0.315 (+0.27%)

CNCE Concert Pharmaceuticals
$6.36 /

+0.5 (+8.53%)

CHPT ChargePoint
$12.75 /

-0.71 (-5.27%)

APPS Digital Turbine
$25.45 /

-1.16 (-4.36%)

AMBA Ambarella
$85.23 /

-2.895 (-3.29%)

  • 02
    Jun
  • 15
    Jul
SIX Six Flags
$29.36 /

-0.64 (-2.13%)

HPQ HP Inc.
$38.79 /

+0.06 (+0.15%)

CRM Salesforce
$160.60 /

-4.5 (-2.73%)

VSCO Victoria's Secret
$41.27 /

-1.37 (-3.21%)

SPWH Sportsman's Warehouse
$9.45 /

-0.11 (-1.15%)

SIX Six Flags
$29.36 /

-0.64 (-2.13%)

OSTK Overstock.com
$31.02 /

-1.295 (-4.01%)

HPQ HP Inc.
$38.79 /

+0.06 (+0.15%)

CRM Salesforce
$160.60 /

-4.5 (-2.73%)

CHPT ChargePoint
$12.75 /

-0.71 (-5.27%)

APPS Digital Turbine
$25.45 /

-1.16 (-4.36%)

AMBA Ambarella
$85.23 /

-2.895 (-3.29%)

VSCO Victoria's Secret
$41.27 /

-1.37 (-3.21%)

SPWH Sportsman's Warehouse
$9.45 /

-0.11 (-1.15%)

OSTK Overstock.com
$31.02 /

-1.295 (-4.01%)

LPI Laredo Petroleum
$84.19 /

-0.75 (-0.88%)

HPQ HP Inc.
$38.79 /

+0.06 (+0.15%)

CRM Salesforce
$160.60 /

-4.5 (-2.73%)

CHPT ChargePoint
$12.75 /

-0.71 (-5.27%)

APPS Digital Turbine
$25.45 /

-1.16 (-4.36%)

AMBA Ambarella
$85.23 /

-2.895 (-3.29%)

Syndicate
Conmed offers to sell $600M in convertible senior notes doe 2027  17:27
05/31/22
05/31
17:27
05/31/22
17:27
CNMD

Conmed

$116.37 /

+0.315 (+0.27%)

 
ShowHide Related Items >><<
CNMD Conmed
$116.37 /

+0.315 (+0.27%)

CNMD Conmed
$116.37 /

+0.315 (+0.27%)

04/19/22 Piper Sandler
Piper Sandler continues to recommend exposure to medtech space after J&J results
03/02/22 BofA
Conmed reinstated with a Neutral at BofA
10/27/21 Piper Sandler
Conmed should be bought on any weakness, says Piper Sandler
10/06/21
Fly Intel: Top five analyst upgrades
CNMD Conmed
$116.37 /

+0.315 (+0.27%)

Over a month ago
Hot Stocks
Conmed to acquire In2Bones Global for $145M » 16:49
05/04/22
05/04
16:49
05/04/22
16:49
CNMD

Conmed

$140.05 /

+5.3 (+3.93%)

CONMED "announced a…

CONMED "announced a definitive agreement to acquire privately-held In2Bones Global, Inc., on a cash-free, debt-free basis, for cash consideration of $145 million at closing and up to an additional $110 million in growth-based earnout payments over a four-year period. The transaction is not subject to a financing condition. The transaction is subject to customary closing conditions, including receipt of U.S. regulatory approval, and is expected to close late in the second quarter or early in the third quarter of 2022."

ShowHide Related Items >><<
CNMD Conmed
$140.05 /

+5.3 (+3.93%)

04/19/22 Piper Sandler
Piper Sandler continues to recommend exposure to medtech space after J&J results
03/02/22 BofA
Conmed reinstated with a Neutral at BofA
10/27/21 Piper Sandler
Conmed should be bought on any weakness, says Piper Sandler
10/06/21
Fly Intel: Top five analyst upgrades
CNMD Conmed
$140.05 /

+5.3 (+3.93%)

Earnings
Conmed cuts FY22 adjusted EPS view to $3.50-$3.65, consensus $3.69 » 16:10
05/04/22
05/04
16:10
05/04/22
16:10
CNMD

Conmed

$139.54 /

+4.79 (+3.55%)

Previous view…

Previous view $3.60-$2.85. Raises FY22 revenue view to $1.105B-$1.15B from $1.075B-$1.125B, consensus $1.09B.

ShowHide Related Items >><<
CNMD Conmed
$139.54 /

+4.79 (+3.55%)

04/19/22 Piper Sandler
Piper Sandler continues to recommend exposure to medtech space after J&J results
03/02/22 BofA
Conmed reinstated with a Neutral at BofA
10/27/21 Piper Sandler
Conmed should be bought on any weakness, says Piper Sandler
10/06/21
Fly Intel: Top five analyst upgrades
CNMD Conmed
$139.54 /

+4.79 (+3.55%)

Earnings
Conmed reports Q1 adjusted EPS 70c, consensus 62c » 16:09
05/04/22
05/04
16:09
05/04/22
16:09
CNMD

Conmed

$139.53 /

+4.78 (+3.55%)

Reports Q1 revenue…

Reports Q1 revenue $242.3M, consensus $235.77M. "I am pleased with our start to the year as we generated momentum and finished the quarter on a strong note," commented Curt R. Hartman, CONMED's Chair of the Board, President, and Chief Executive Officer. "While we are facing larger than anticipated inflationary pressures, we remain confident in our longer-term prospects for both top and bottom-line growth."

ShowHide Related Items >><<
CNMD Conmed
$139.53 /

+4.78 (+3.55%)

04/19/22 Piper Sandler
Piper Sandler continues to recommend exposure to medtech space after J&J results
03/02/22 BofA
Conmed reinstated with a Neutral at BofA
10/27/21 Piper Sandler
Conmed should be bought on any weakness, says Piper Sandler
10/06/21
Fly Intel: Top five analyst upgrades
CNMD Conmed
$139.53 /

+4.78 (+3.55%)

Recommendations
Piper Sandler continues to recommend exposure to medtech space after J&J results » 11:33
04/19/22
04/19
11:33
04/19/22
11:33
JNJ

Johnson & Johnson

$184.63 /

+6.99 (+3.93%)

, ATRC

AtriCure

$59.64 /

+3.94 (+7.07%)

, BSX

Boston Scientific

$45.68 /

+1.95 (+4.46%)

, COO

Cooper Companies

$409.16 /

+13.93 (+3.52%)

, GMED

Globus Medical

$76.86 /

+0.53 (+0.69%)

, MDT

Medtronic

$111.10 /

+3.055 (+2.83%)

, NUVA

NuVasive

$59.89 /

+3.56 (+6.32%)

, SYK

Stryker

$271.35 /

+12.57 (+4.86%)

, ZBH

Zimmer Biomet

$129.15 /

+4.02 (+3.21%)

, ATEC

Alphatec

$12.66 /

+0.585 (+4.84%)

, SPNE

SeaSpine

$10.81 /

+0.49 (+4.75%)

, STXS

Stereotaxis

$3.30 /

+0.005 (+0.15%)

, CNMD

Conmed

$148.80 /

+6.55 (+4.60%)

, ISRG

Intuitive Surgical

$292.77 /

+17.06 (+6.19%)

, GKOS

Glaukos

$61.26 /

+1.99 (+3.36%)

, SGHT

Sight Sciences

$8.77 /

+0.04 (+0.46%)

Piper Sandler analyst…

Piper Sandler analyst Matt O'Brien notes that Johnson & Johnson (JNJ) reported Q1 med device sales of $6.97B, coming in well ahead of the Street's $6.65B. Within med devices, all four business segments beat Street expectations led by Interventional which grew +17.4% and Vision which grew +13.9%, the author notes, adding that J&J did lower its revenue and EPS guidance on a full-company basis for the year though this was due to lower vaccine sales and higher currency headwinds, respectively. Notably, Johnson & Johnson did not lower its operating margin expectations as some had feared, O'Brien points out. Overall, the analyst views the results as better than expected, and continues to recommend exposure to the medtech space in 2022. Related companies in the sector include AtriCure (ATRC), Boston Scientific (BSX), Cooper Companies (COO), Globus Medical (GMED), Medtronic (MDT), NuVasive (NUVA), Stryker (SYK), Zimmer Biomet (ZBH), Alphatec (ATEC), SeaSpine (SPNE), Stereotaxis (STXS), Conmed (CNMD), Intuitive Surgical (ISRG), Glaukos (GKOS), and Sight Sciences (SGHT).

ShowHide Related Items >><<
ZBH Zimmer Biomet
$129.15 /

+4.02 (+3.21%)

SYK Stryker
$271.35 /

+12.57 (+4.86%)

STXS Stereotaxis
$3.30 /

+0.005 (+0.15%)

SPNE SeaSpine
$10.81 /

+0.49 (+4.75%)

SGHT Sight Sciences
$8.77 /

+0.04 (+0.46%)

NUVA NuVasive
$59.89 /

+3.56 (+6.32%)

MDT Medtronic
$111.10 /

+3.055 (+2.83%)

JNJ Johnson & Johnson
$184.63 /

+6.99 (+3.93%)

ISRG Intuitive Surgical
$292.77 /

+17.06 (+6.19%)

GMED Globus Medical
$76.86 /

+0.53 (+0.69%)

GKOS Glaukos
$61.26 /

+1.99 (+3.36%)

COO Cooper Companies
$409.16 /

+13.93 (+3.52%)

BSX Boston Scientific
$45.68 /

+1.95 (+4.46%)

JNJ Johnson & Johnson
$184.63 /

+6.99 (+3.93%)

04/19/22 BTIG
J&J results will be viewed favorably for MedTech group, says BTIG
04/14/22 Raymond James
Johnson & Johnson price target raised to $195 from $185 at Raymond James
04/06/22 Morgan Stanley
Johnson & Johnson assumed with an Equal Weight at Morgan Stanley
03/16/22 Bernstein
Bernstein downgrades J&J on 'uphill battle' for Janssen unit
ATRC AtriCure
$59.64 /

+3.94 (+7.07%)

02/16/22 Needham
AtriCure price target lowered to $79 from $92 at Needham
02/16/22 Canaccord
AtriCure price target lowered to $88 from $120 at Canaccord
01/03/22 JPMorgan
JPMorgan says own these medical device stocks into next week's conference
09/16/21 JPMorgan
AtriCure should be bought ahead of 'exciting' 2022, says JPMorgan
BSX Boston Scientific
$45.68 /

+1.95 (+4.46%)

04/12/22 Truist
Truist starts six stocks in Medical Supplies and Devices, assumes eight others
04/12/22 Truist
Boston Scientific assumed with a Buy at Truist
04/06/22 JPMorgan
JPMorgan 'tentatively bullish' on medtech, sees two best positioned
03/02/22 BofA
Boston Scientific added to US 1 List at BofA
COO Cooper Companies
$409.16 /

+13.93 (+3.52%)

04/08/22 Needham
Cooper Companies initiated with a Hold at Needham
03/07/22 Stephens
Cooper Companies price target raised to $500 from $430 at Stephens
03/04/22 Piper Sandler
Cooper Companies price target raised to $500 from $490 at Piper Sandler
01/03/22 Guggenheim
Guggenheim upgrades Cooper Companies to Buy ahead of myopia franchise inflection
GMED Globus Medical
$76.86 /

+0.53 (+0.69%)

04/12/22 Truist
Globus Medical assumed with a Buy at Truist
03/28/22 Wells Fargo
Globus Medical initiated with an Overweight at Wells Fargo
MDT Medtronic
$111.10 /

+3.055 (+2.83%)

04/12/22 Truist
Medtronic assumed at Hold from Buy at Truist
03/01/22 BofA
Medtronic reinstated with a Buy at BofA
02/23/22 Credit Suisse
Medtronic price target lowered to $135 from $142 at Credit Suisse
NUVA NuVasive
$59.89 /

+3.56 (+6.32%)

04/12/22 Truist
NuVasive assumed with a Buy at Truist
03/28/22 Wells Fargo
Wells Fargo bullish on NuVasive, initiates with an Overweight
SYK Stryker
$271.35 /

+12.57 (+4.86%)

04/18/22 BTIG
Stryker price target raised to $278 from $273 at BTIG
04/12/22 Truist
Stryker initiated with a Hold at Truist
ZBH Zimmer Biomet
$129.15 /

+4.02 (+3.21%)

04/12/22 Truist
Zimmer Biomet assumed at Hold from Buy at Truist
04/01/22 Citi
Zimmer Biomet downgraded to Neutral from Buy at Citi
ATEC Alphatec
$12.66 /

+0.585 (+4.84%)

03/02/22 Piper Sandler
Alphatec price target lowered to $17 from $22 at Piper Sandler
12/03/21 Goldman Sachs
Alphatec initiated with a Neutral at Goldman Sachs
10/28/21 Loop Capital
Alphatec initiated with a Buy at Loop Capital
09/28/21 Piper Sandler
Piper Sandler still bullish on Alphatec, views any weakness as good entry point
SPNE SeaSpine
$10.81 /

+0.49 (+4.75%)

04/12/22 Truist
SeaSpine assumed with a Buy at Truist
03/14/22 Piper Sandler
SeaSpine price target lowered to $21 from $28 at Piper Sandler
STXS Stereotaxis
$3.30 /

+0.005 (+0.15%)

03/03/22 Piper Sandler
Piper Sandler keeps Overweight on Stereotaxis, lowers price target to $8
01/05/22 Craig-Hallum
Craig-Hallum bullish on Stereotaxis, initiates with a Buy
01/05/22 Craig-Hallum
Stereotaxis initiated with a Buy at Craig-Hallum
01/05/22 Loop Capital
Stereotaxis initiated with a Buy at Loop Capital
CNMD Conmed
$148.80 /

+6.55 (+4.60%)

03/02/22 BofA
Conmed reinstated with a Neutral at BofA
10/27/21 Piper Sandler
Conmed should be bought on any weakness, says Piper Sandler
10/06/21
Fly Intel: Top five analyst upgrades
10/06/21 Needham
Conmed upgraded to Buy at Needham on double-digit revenue growth outlook
ISRG Intuitive Surgical
$292.77 /

+17.06 (+6.19%)

04/13/22 Deutsche Bank
Intuitive Surgical antitrust case heading to trial, says Deutsche Bank
04/12/22 Truist
Intuitive Surgical initiated with a Buy at Truist
GKOS Glaukos
$61.26 /

+1.99 (+3.36%)

04/18/22 BTIG
Glaukos price target raised to $66 from $61 at BTIG
03/02/22 Stifel
Glaukos transferred with Hold rating at Stifel
02/23/22 Citi
Glaukos price target raised to $55 from $49 at Citi
SGHT Sight Sciences
$8.77 /

+0.04 (+0.46%)

03/25/22 Citi
Sight Sciences price target lowered to $35 from $39 at Citi
03/25/22 Piper Sandler
Sight Sciences price target lowered to $23 from $43 at Piper Sandler
02/03/22 William Blair
William Blair starts Sight Sciences at Outperform on 'massive opportunity'
02/03/22 William Blair
Sight Sciences initiated with an Outperform at William Blair
ZBH Zimmer Biomet
$129.15 /

+4.02 (+3.21%)

SYK Stryker
$271.35 /

+12.57 (+4.86%)

STXS Stereotaxis
$3.30 /

+0.005 (+0.15%)

SPNE SeaSpine
$10.81 /

+0.49 (+4.75%)

SGHT Sight Sciences
$8.77 /

+0.04 (+0.46%)

NUVA NuVasive
$59.89 /

+3.56 (+6.32%)

MDT Medtronic
$111.10 /

+3.055 (+2.83%)

JNJ Johnson & Johnson
$184.63 /

+6.99 (+3.93%)

ISRG Intuitive Surgical
$292.77 /

+17.06 (+6.19%)

GMED Globus Medical
$76.86 /

+0.53 (+0.69%)

GKOS Glaukos
$61.26 /

+1.99 (+3.36%)

COO Cooper Companies
$409.16 /

+13.93 (+3.52%)

CNMD Conmed
$148.80 /

+6.55 (+4.60%)

BSX Boston Scientific
$45.68 /

+1.95 (+4.46%)

ATRC AtriCure
$59.64 /

+3.94 (+7.07%)

ATEC Alphatec
$12.66 /

+0.585 (+4.84%)

  • 15
    Jul
SYK Stryker
$271.35 /

+12.57 (+4.86%)

MDT Medtronic
$111.10 /

+3.055 (+2.83%)

JNJ Johnson & Johnson
$184.63 /

+6.99 (+3.93%)

ISRG Intuitive Surgical
$292.77 /

+17.06 (+6.19%)

GMED Globus Medical
$76.86 /

+0.53 (+0.69%)

BSX Boston Scientific
$45.68 /

+1.95 (+4.46%)

ZBH Zimmer Biomet
$129.15 /

+4.02 (+3.21%)

SYK Stryker
$271.35 /

+12.57 (+4.86%)

SPNE SeaSpine
$10.81 /

+0.49 (+4.75%)

SGHT Sight Sciences
$8.77 /

+0.04 (+0.46%)

MDT Medtronic
$111.10 /

+3.055 (+2.83%)

JNJ Johnson & Johnson
$184.63 /

+6.99 (+3.93%)

ISRG Intuitive Surgical
$292.77 /

+17.06 (+6.19%)

GMED Globus Medical
$76.86 /

+0.53 (+0.69%)

GKOS Glaukos
$61.26 /

+1.99 (+3.36%)

COO Cooper Companies
$409.16 /

+13.93 (+3.52%)

BSX Boston Scientific
$45.68 /

+1.95 (+4.46%)

ZBH Zimmer Biomet
$129.15 /

+4.02 (+3.21%)

SYK Stryker
$271.35 /

+12.57 (+4.86%)

MDT Medtronic
$111.10 /

+3.055 (+2.83%)

JNJ Johnson & Johnson
$184.63 /

+6.99 (+3.93%)

ISRG Intuitive Surgical
$292.77 /

+17.06 (+6.19%)

GKOS Glaukos
$61.26 /

+1.99 (+3.36%)

COO Cooper Companies
$409.16 /

+13.93 (+3.52%)

BSX Boston Scientific
$45.68 /

+1.95 (+4.46%)

Over a quarter ago
Initiation
Conmed reinstated with a Neutral at BofA » 05:09
03/02/22
03/02
05:09
03/02/22
05:09
CNMD

Conmed

$144.45 /

-1.755 (-1.20%)

BofA analyst Travis Steed…

BofA analyst Travis Steed reinstated coverage of Conmed with a Neutral rating and $155 price target. The analyst is more confident in the company's margin outlook but says the stock looks fairly valued at these levels relative to other opportunities in medtech.

ShowHide Related Items >><<
CNMD Conmed
$144.45 /

-1.755 (-1.20%)

10/27/21 Piper Sandler
Conmed should be bought on any weakness, says Piper Sandler
10/06/21
Fly Intel: Top five analyst upgrades
10/06/21 Needham
Conmed upgraded to Buy at Needham on double-digit revenue growth outlook
10/06/21 Needham
Conmed upgraded to Buy from Hold at Needham
CNMD Conmed
$144.45 /

-1.755 (-1.20%)

Earnings
Conmed sees FY22 adjusted EPS $3.60-$3.85, consensus $3.74 » 16:10
01/26/22
01/26
16:10
01/26/22
16:10
CNMD

Conmed

$121.61 /

-2.22 (-1.79%)

Sees FY22 revenue…

Sees FY22 revenue $1.075B-$1.125B, consensus $1.11B.

ShowHide Related Items >><<
CNMD Conmed
$121.61 /

-2.22 (-1.79%)

10/27/21 Piper Sandler
Conmed should be bought on any weakness, says Piper Sandler
10/06/21
Fly Intel: Top five analyst upgrades
10/06/21 Needham
Conmed upgraded to Buy at Needham on double-digit revenue growth outlook
10/06/21 Needham
Conmed upgraded to Buy from Hold at Needham
CNMD Conmed
$121.61 /

-2.22 (-1.79%)

CNMD Conmed
$121.61 /

-2.22 (-1.79%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.